Akebia Therapeutics, Inc.

BNP PARIBAS FINANCIAL MARKETS AKBA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

730,409

Value ($000)

1,176

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	1,176	0.0%	730,409	12/31/2025
2025 Q3	11/13/2025	2,344	0.0%	858,541	9/30/2025
2025 Q2	8/14/2025	1,895	0.0%	520,629	6/30/2025
2025 Q1	5/14/2025	92	0.0%	47,774	3/31/2025
2024 Q4	2/14/2025	66	0.0%	34,599	12/31/2024
2024 Q3	11/13/2024	61	0.0%	46,270	9/30/2024
2024 Q2	8/13/2024	15	0.0%	15,133	6/30/2024
2024 Q1	5/1/2024	0	0.0%	171	3/31/2024
2023 Q4	2/14/2024	11	0.0%	8,848	12/31/2023
2023 Q3	11/14/2023	10	0.0%	8,848	9/30/2023
2023 Q2	8/9/2023	8	0.0%	8,683	6/30/2023
2023 Q1	5/12/2023	5	0.0%	8,683	3/31/2023
2022 Q4	2/14/2023	5	0.0%	9,529	12/31/2022
2022 Q3	11/16/2022	8	0.0%	24,815	9/30/2022
2022 Q2	8/12/2022	32	0.0%	90,540	6/30/2022
2022 Q1	5/18/2022	29	0.0%	40,474	3/31/2022
2021 Q4	2/9/2022	160	0.0%	70,923	12/31/2021
2021 Q3	11/16/2021	225	0.0%	78,029	9/30/2021
2021 Q2	8/10/2021	239	0.0%	63,068	6/30/2021
2021 Q1	5/7/2021	252	0.0%	74,568	3/31/2021
2020 Q4	2/10/2021	58	0.0%	20,629	12/31/2020
2020 Q3	10/30/2020	85	0.0%	33,995	9/30/2020
2020 Q2	8/6/2020	154	0.0%	11,334	6/30/2020
2020 Q1	5/13/2020	355	0.0%	46,843	3/31/2020
2019 Q4	2/12/2020	88	0.0%	13,952	12/31/2019